AstraZeneca admits in court that its covid-19 vaccine can cause thrombosis
A class action lawsuit was filed by a few recipients of the biologic vaccination against the large pharmaceutical company and the Covid-19 vaccine.
According to the British daily The Telegraph, AstraZeneca, the laboratory, admitted for the first time in court records that its COVID-19 vaccination may, in extremely rare circumstances, result in thrombosis.
Some recipients of the biologic filed a class action lawsuit against the multinational pharmaceutical company and its Covid-19 vaccine, which was created in collaboration with Oxford University in the United Kingdom. They claimed that the vaccination may have resulted in numerous incidents of death or significant damage.
The first case, as reported by The Telegraph, was filed in 2023 by Jamie Scott, a father of two who received the vaccination in April 2021 and was left permanently disabled due to a blood clot and brain hemorrhage that prohibited him from working.
The newspaper reports that while AstraZeneca has denied the allegations, it acknowledged in a court filing in February that its Covid-19 vaccination “may, in very rare cases, cause STT,” which stands for thrombosis syndrome with thrombocytopenia, a condition that results in blood clots and a low platelet count.
The victims and their families have brought 51 claims in the British High Court thus far, seeking damages valued at £100 million.
If it turns out that the plaintiffs’ sickness was brought on by the vaccination, the pharmaceutical company’s admission of this unusual side effect might result in payouts, according to The Telegraph.
